MS related TN is known to be a challenge to effectively treat and is a major cause of debility for these patients. Despite its impact on quality of life, clinical features and management strategies specific to TN secondary to MS are limited.
A prospective review was conducted of patients within the University of Utah Healthcare system who met the following criteria: (1) clinically definite MS (McDonald 2017) (2) met American Academy of Neurology ‘s (AAN) diagnostic criteria for TN (3) were seen at University of Utah MS clinic between the dates of 1/2017 and 9/2022. TN pain was assessed with a questionnaire to determine pain characteristics and severity over time. MRI brain and cervical spine were evaluated for relevant lesions. Treatment (including both pharmacologic and non-pharmacologic) along with outcomes were monitored.
MS patients with TN experienced neurogenic pain of multiple types and high severity. MRI correlates of TN in brainstem or cervical cord were frequently observed. Pharmacological interventions, especially oxcarbazepine and gabapentin were frequently beneficial. Further evaluation of gamma knife procedure in MS related TN should be investigated.